FAST NEWS: Legend Biotech Plummets on Proposed $300 Million Share Sale
The latest: Biopharmaceutical company Legend Biotech Corp. (LEGN.US) has proposed offering $300 million in American Depositary Shares (ADSs), with the option for underwriters to sell an additional $45 million worth…
RELATED ARTICLES
-
GenScript losses shrink on strong growth for cancer cell therapy
1548.HK
-
Legend Holdings shows diversification isn’t always a winning formula
3396.HK
-
FAST NEWS: Legend Biotech to raise $300 million from share sale
LEGN.US 1548.HK
-
FAST NEWS: Hillhouse invests $22 million in Legend Biotech
LEGN.US
-
FAST NEWS: Legend Biotech shares jump on rising cancer drug sales
LEGN.US
-
Cash-strapped Viva Biotech sells stake and plans spinoff
1873.HK
Discover hidden China stock gems in our weekly newsletter